Use of the visual analog scale of craving in addiction medicine: advantages and limitations of the method
https://doi.org/10.31363/2313-7053-2025-3-1114
Abstract
Craving for psychoactive substances is a hallmark feature of psychoactive substance use and one of the central symptoms of substance use disorder in the DSM-5 and ICD-10. However, the debates about its precise definition, operationalization, and appropriate methods of assessment continue to this day, thus underscoring the complexity and multifaceted nature of this phenomenon. Understanding the mechanisms and dynamics of craving holds significant theoretical and practical implications for both research and clinical practice. The article explores the challenges inherent in conceptualizing craving and discusses the main strengths and limitations of current assessment methods, including self-report and experimental approaches, with a particular focus on visual analog scales (VAS). The VAS are widely regarded as rapid, simple and flexible tool that is adaptable to diverse research paradigms, requires minimal financial and time investments, places minimal low demands on respondents. Recent studies further demonstrated that the VAS has acceptable psychometric properties for assessing craving. Nevertheless, the use of VAS has its limitations. In addition to the inherent constraints of self-report methods, such as reliance on self-reflection, the VAS requires a clear definition of the construct being measured, lacks norms or thresholds, and maybe affected by the variability of how the respondents interpret maximum and intermediate scale values. When employing the VAS to assess craving, it is essential to account for the dynamic and multifaceted nature of the phenomenon. This requires careful selection of the terminology used in the instruction, the choice of the specific aspects of craving being measured, the temporal framework of assessment (“here and now” vs over a defined period of time), and the frequency and duration of measurement.
Supporting agencies: The study was conducted within the framework of a state-funded project at the V.M. Bekhterev National Research Medical Center for Psychiatry and Neurology from 2024 to 2026 (XSOZ-2024-0014).
About the Authors
Evgeny M. Krupitsky
V.M. Bekhterev National Research Medical Centre for Psychiatry and Neurology; I.P. Pavlov First St. Petersburg State Medical University
Russian Federation
Russian Federation
Saint Petersburg
Elvina A. Akhmetova
V.M. Bekhterev National Research Medical Centre for Psychiatry and Neurology; Bashkir State Medical University
Russian Federation
Russian Federation
Saint Petersburg; Ufa
Svetlana G. Klimanova
V.M. Bekhterev National Research Medical Centre for Psychiatry and Neurology
Russian Federation
Russian Federation
Saint Petersburg
References
1. Bryun EA, Pochitaeva IP. Economic effectiveness of measures to counteract the spread of drug addiction and alcoholism. Menedzher zdravoohraneniya. 2016;(2):13-20. (In Russ.).
2. Klimanova SG, Bornovalova MA, Emmanuil P et al. Adaptation of the Russian version of the Obsessive-Compulsive Alcohol Use Scale. Obozrenie psihiatrii i medicinskoj psihologii im. V.M. Bekhtereva. 2024;58(4-1):73-90. (In Russ.). https://doi.org/10.31363/2313-7053-2024-981.
3. Krupitsky EM, Grinenko AYa. Nonverbal (color) repertoire grids: research methodology. Obozrenie psihiatrii i medicinskoj psihologii im. V.M. Bekhtereva. 1995;(3):51-57. (In Russ.).
4. Krupitsky EM, Rudenko AA, Tsoy MV et al. Phenomenology of pathological craving for alcohol in patients with alcoholism in remission: association with disease relapse. Voprosy narkologii. 2003;(6):15-19. (In Russ.).
5. Krupitsky EM, Trusova AV. Psychosemantic approach to the clinic of addictions — methodology of using nonverbal (color) repertoire grids. Voprosy narkologii. 2017;(12):44-56. (In Russ.).
6. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: APA; 2013. https://doi.org/10.1176/appi.books.9780890425596.
7. Anton RF, Moak DH, Latham P. The Obsessive Compulsive Drinking Scale: A Self-Rated Instrument for the Quantification of Thoughts about Alcohol and Drinking Behavior. Alcoholism: Clinical and Experimental Research. 1995;19(1):92-99. https://doi.org/10.1111/j.1530-0277.1995.tb01475.x.
8. Anton RF. The Obsessive Compulsive Drinking Scale: A New Method of Assessing Outcome in Alcoholism Treatment Studies. Archives of General Psychiatry. 1996;53(3):225-231. https://doi.org/10.1001/archpsyc.1996.01830030047008.
9. Åström M, Thet Lwin ZM, Teni FS et al. Use of the visual analogue scale for health state valuation: A scoping review. Quality of Life Research. 2023;32(10):2719-2729. https://doi.org/10.1007/s11136-023-03411-3.
10. Baker TB, Piper ME, McCarthy DE et al. Addiction motivation reformulated: an affective processing model of negative reinforcement. Psychological Review. 2004;111(1):33-51.
11. Bergeria CL, Strickland JC, Huhn AS et al. A preliminary examination of the multiple dimensions of opioid craving. Drug and Alcohol Dependence. 2021;219:108473. https://doi.org/10.1016/j.drugalcdep.2020.108473.
12. Boyett B, Wiest K, McLeod LD et al. Assessment of craving in opioid use disorder: Psychometric evaluation and predictive validity of the opioid craving VAS. Drug and Alcohol Dependence. 2021;229:109057. https://doi.org/10.1016/j.drugalcdep.2021.109057.
13. Bradizza CM, Stasiewicz PR, Paas ND. Relapse to alcohol and drug use among individuals diagnosed with co-occurring mental health and substance use disorders: A review. Clinical Psychology Review. 2006;26(2):162-178. https://doi.org/10.1016/j.cpr.2005.11.005.
14. Byrom B, Elash CA, Eremenco S et al. Measurement Comparability of Electronic and Paper Administration of Visual Analogue Scales: A Review of Published Studies. Therapeutic Innovation & Regulatory Science. 2022;56(3):394-404. https://doi.org/10.1007/s43441-022-00376-2.
15. Cavicchioli M, Vassena G, Movalli M et al. Is craving a risk factor for substance use among treatment-seeking individuals with alcohol and other drugs use disorders? A meta-analytic review. Drug and Alcohol Dependence. 2020;212:108002. https://doi.org/10.1016/j.drugalcdep.2020.108002.
16. Cloos L, Siepe BS, Piccirillo M et al. Accuracy and Consistency of Visual Analog Scales in Ecological Momentary Assessment and Digital Studies. 2025. https://doi.org/10.31219/osf.io/h2p4w_v1.
17. Flannery BA, Volpicelli JR, Pettinati HM. Psychometric properties of the Penn Alcohol Craving Scale. Alcoholism: Clinical and Experimental Research. 1999;23(8):1289-1295.
18. Fleury M.-J., Djouini A., Huỳnh C. et al. Remission from substance use disorders: A systematic review and meta-analysis. Drug and Alcohol Dependence. 2016;168:293-306. https://doi.org/10.1016/j.drugalcdep.2016.08.625.
19. Goodyear K, Haass-Koffler CL. Opioid craving in human laboratory settings: A review of the challenges and limitations. Neurotherapeutics. 2020;17(1):100-104. https://doi.org/10.1007/s13311-019-00822-4.
20. Haass-Koffler CL, Leggio L, Kenna GA. Pharmacological approaches to reducing craving in patients with alcohol use disorders. CNS Drugs. 2014;28:343-360. https://doi.org/10.1007/s40263-014-0149-3.
21. Hartwell EE, Ray LA. Relationship between tonic and phasic craving for alcohol. Addictive Behaviors Reports. 2018;7:71-74. https://doi.org/10.1016/j.abrep.2018.03.001.
22. Hayes JE, Allen AL, Bennett SM. Direct comparison of the generalized visual analog scale (gVAS) and general labeled magnitude scale (gLMS). Food Quality and Preference. 2013;28(1):36-44. https://doi.org/10.1016/j.foodqual.2012.07.012.
23. Heller GZ, Manuguerra M, Chow R. How to analyze the Visual Analogue Scale: Myths, truths and clinical relevance. Scandinavian Journal of Pain. 2016;13(1):67-75. https://doi.org/10.1016/j.sjpain.2016.06.012.
24. Kakko J, Alho H, Baldacchino A et al. Craving in opioid use disorder: from neurobiology to clinical practice. Frontiers in Psychiatry. 2019;10:466627. https://doi.org/10.3389/fpsyt.2019.00592.
25. Kavanagh DJ, Statham DJ, Feeney GFX et al. Measurement of alcohol craving. Addictive Behaviors. 2013;38(2):1572-1584. https://doi.org/10.1016/j.addbeh.2012.08.004.
26. Kleykamp BA, De Santis M, Dworkin RH et al. Craving and opioid use disorder: A scoping review. Drug and Alcohol Dependence. 2019;205:107639. https://doi.org/10.1016/j.drugalcdep.2019.107639.
27. Koban L, Wager TD, Kober H. A neuromarker for drug and food craving distinguishes drug users from non-users. Nature Neuroscience. 2023;26(2):316-325. https://doi.org/10.1038/s41593-022-01228-w.
28. Krupitsky E.M., Romanova T.N., Tsoy-Podosenin M.V. The use of verbal and colored repertory grids to explore the attitude to drug abstinence in heroin addicts. In: Boutros N., ed. Yearbook of International Psychiatry and Behavioral Neurosciences. Vol. 1. New York: NOVA Science Publishers; 2009.
29. Krupitsky EM, Zvartau EE, Masalov DV et al. Naltrexone with or without fluoxetine for preventing relapse to heroin addiction in St. Petersburg, Russia. Journal of Substance Abuse Treatment. 2006;31(4):319-328. https://doi.org/10.1016/j.jsat.2006.05.005.
30. Krupitsky EM, Zvartau EE, Masalov DV et al. Naltrexone for heroin dependence treatment in St. Petersburg, Russia. Journal of Substance Abuse Treatment. 2004;26(4):285-294. https://doi.org/10.1016/j.jsat.2004.02.002.
31. Krupitsky E, Nunes EV, Ling W et al. Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial. The Lancet. 2011;377(9776):1506-1513. https://doi.org/10.1016/S0140-6736(11)60358-9.
32. Krupitsky E, Zvartau E, Blokhina E et al. Randomized trial of long-acting sustained-release naltrexone implant vs oral naltrexone or placebo for preventing relapse to opioid dependence. Archives of General Psychiatry. 2012;69(9):973-981. https://doi.org/10.1001/archgenpsychiatry.2012.1a.
33. Krupitsky E, Zvartau E, Blokhina E et al. Anhedonia, depression, anxiety, and craving in opiate dependent patients stabilized on oral naltrexone or an extended release naltrexone implant. The American Journal of Drug and Alcohol Abuse. 2016;42(5):614-620. https://doi.org/10.1080/00952990.2016.1197231.
34. Lee JW, Brown ES, Perantie DC et al. A Comparison of Single-Item Visual Analog Scales With a Multiitem Likert-Type Scale for Assessment of Cocaine Craving in Persons With Bipolar Disorder. Addictive Disorders & Their Treatment. 2002;1(4):140-142. https://doi.org/10.1097/00132576-200211000-00005.
35. Marlatt G.A. Craving for alcohol, loss of control, and relapse: A cognitive-behavioral analysis. In: Nathan P.E., Marlatt G.A., eds. Alcoholism: New directions in behavioral research and treatment. New York: Plenum Press; 1978.
36. McHugh RK, Fitzmaurice GM, Carroll KM et al. Assessing craving and its relationship to subsequent prescription opioid use among treatment-seeking prescription opioid dependent patients. Drug and Alcohol Dependence. 2014;145:121-126. https://doi.org/10.1016/j.drugalcdep.2014.10.002.
37. McHugh RK, Fulciniti F, Mashhoon Y et al. Cue-induced craving to paraphernalia and drug images in opioid dependence. The American Journal on Addictions. 2016;25(2):105-109. https://doi.org/10.1111/ajad.12334.
38. Miele C, Cabé J, Cabé N et al. Measuring craving: A systematic review and mapping of assessment instruments. What about sexual craving? Addiction. 2023;118(4):1-18. https://doi.org/10.1111/add.16287.
39. Rankin H, Hodgson R, Stockwell T. The concept of craving and its measurement. Behaviour Research and Therapy. 1979;17(4):389-396. https://doi.org/10.1016/0005-7967(79)90011-6.
40. Ray LA, Bujarski S, Yardley M.M. et al. Differences between treatment-seeking and non-treatment-seeking participants in medication studies for alcoholism: do they matter? The American Journal of Drug and Alcohol Abuse. 2017;43(6):703-710. https://doi.org/10.1080/00952990.2017.1312423.
41. Rezvanian S. Saraei M, Mohajeri H et al. The effect of different transcranial direct current stimulation (tDCS) protocols on drug craving and cognitive functions in methamphetamine addicts. Basic and Clinical Neuroscience. 2022;13(3):349-358. https://doi.org/10.32598/bcn.2022.3430.1.
42. Rosenberg H. Defining and Assessing Drug Craving. In: Miller P.M., ed. Principles of Addiction. San Diego: Academic Press; 2013. https://doi.org/10.1016/B978-0-12-398336-7.00040-1.
43. Sayette MA. The role of craving in substance use disorders: theoretical and methodological issues. Annual Review of Clinical Psychology. 2016;12:407-433. https://doi.org/10.1146/annurev-clinpsy-021815-093351.
44. Sayette MA, Shiffman S, Tiffany ST et al. The measurement of drug craving. Addiction. 2000;95(8s2):189-210. https://doi.org/10.1046/j.1360-0443.95.8s2.8.x.
45. Serre F, Fatseas M, Swendsen J et al. Ecological momentary assessment in the investigation of craving and substance use in daily life: A systematic review. Drug and Alcohol Dependence. 2015;148:1-20. https://doi.org/10.1016/j.drugalcdep.2014.12.024.
46. Skinner MD, Aubin H-J. Craving’s place in addiction theory: Contributions of the major models. Neuroscience & Biobehavioral Reviews. 2010;34(4):606-623. https://doi.org/10.1016/j.neubiorev.2009.11.024.
47. Sudakin D. Naltrexone: not just for opioids anymore. Journal of Medical Toxicology. 2016;12:71-75. https://doi.org/10.1007/s13181-015-0522-8.
48. Tiffany ST. Cognitive concepts of craving. Alcohol Research & Health. 1999;23(3):215-224.
49. U.S. Food and Drug Administration. Guidance for industry: Patient-reported outcome measures: Use in medical product development to support labeling claims. Silver Spring: U.S. Department of Health and Human Services; 2009.
50. Vafaie N, Kober H. Association of Drug Cues and Craving With Drug Use and Relapse: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2022;79(7):641-650. https://doi.org/10.1001/jamapsychiatry.2022.1240.
51. Van Lier HG, Pieterse ME, Schraagen JMC et al. Identifying viable theoretical frameworks with essential parameters for real-time and real world alcohol craving research: A systematic review of craving models. Addiction Research & Theory. 2018;26(1):35-51. https://doi.org/10.1080/16066359.2017.1309525.
52. Volkow ND, Michaelides M, Baler R. The Neuroscience of Drug Reward and Addiction. Physiological Reviews. 2019;99(4):2115-2140. https://doi.org/10.1152/physrev.00014.2018.
53. Wewers ME, Lowe NK. A critical review of visual analogue scales in the measurement of clinical phenomena. Research in Nursing & Health. 1990;13(4):227-236. https://doi.org/10.1002/nur.4770130405.
54. World Health Organization. Alcohol and alcoholism: Report of a WHO Expert Committee. Geneva: WHO; 1955.
Review
For citations:
Krupitsky E.M., Akhmetova E.A., Klimanova S.G. Use of the visual analog scale of craving in addiction medicine: advantages and limitations of the method. V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY. (In Russ.) https://doi.org/10.31363/2313-7053-2025-3-1114
Views:
21
Email this article 